469 related articles for article (PubMed ID: 14742676)
1. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
4. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
7. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
Milligan SA; Owens MW; Grisham MB
Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
[TBL] [Abstract][Full Text] [Related]
9. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
Qin Z; Wang Y; Chasea TN
Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244
[TBL] [Abstract][Full Text] [Related]
10. Effect of proteasome inhibitors on monocytic IkappaB-alpha and -beta depletion, NF-kappaB activation, and cytokine production.
Haas M; Page S; Page M; Neumann FJ; Marx N; Adam M; Ziegler-Heitbrock HW; Neumeier D; Brand K
J Leukoc Biol; 1998 Mar; 63(3):395-404. PubMed ID: 9500529
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
Hellerbrand C; Jobin C; Iimuro Y; Licato L; Sartor RB; Brenner DA
Hepatology; 1998 May; 27(5):1285-95. PubMed ID: 9581682
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
14. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha.
Mukhopadhyay A; Manna SK; Aggarwal BB
J Biol Chem; 2000 Mar; 275(12):8549-55. PubMed ID: 10722693
[TBL] [Abstract][Full Text] [Related]
15. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.
Robbesyn F; Garcia V; Auge N; Vieira O; Frisach MF; Salvayre R; Negre-Salvayre A
FASEB J; 2003 Apr; 17(6):743-5. PubMed ID: 12586748
[TBL] [Abstract][Full Text] [Related]
16. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
Kim HT; Qiang W; Wong PK; Stoica G
J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
[TBL] [Abstract][Full Text] [Related]
17. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
Roussel RR; Barchowsky A
Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.
Pajonk F; Pajonk K; McBride WH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1025-32. PubMed ID: 10863075
[TBL] [Abstract][Full Text] [Related]
19. CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation.
Lenert P; Stunz L; YI AK; Krieg AM; Ashman RF
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):247-56. PubMed ID: 11572601
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro.
Milligan SA; Nopajaroonsri C
Anticancer Res; 2001; 21(1A):39-44. PubMed ID: 11299767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
